alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc

Term ID

CHEBI:61793

Synonyms

(Gal)1 (GlcNAc)1 (LFuc)1 (Neu5Ac)1
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose
CA19-9
CA19-9 antigen
carbohydrate antigen 19-9
NeuAcalpha2,3Galbeta1-3[Fucalpha1-4]GlcNAc
sialyl Lewis A
sialyl Lewis a antigen
sialyl-Lewis(A)

Definition

A branched amino tetrasaccharide consisting of a sialyl residue, linked (2→3) to a galactosyl residue that in turn is linked (1→3) to a glucosaminyl residue, which is also carrying a fucosyl residue at the 4-position.

References

glygen:G81971FM
glytoucan:G81971FM
kegg.glycan:G00257
pubmed:15697247
pubmed:16133831
wikipedia.en:CA19-9

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc

Phenotype where environments contain alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc

Phenotype modified by environments containing alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc

Phenotype affecting alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc

Human Disease Model